DOXYCIN TAB 100MG TABLET

Pays: Canada

Langue: anglais

Source: Health Canada

Ingrédients actifs:

DOXYCYCLINE (DOXYCYCLINE HYCLATE)

Disponible depuis:

LABORATOIRE RIVA INC.

Code ATC:

J01AA02

DCI (Dénomination commune internationale):

DOXYCYCLINE

Dosage:

100MG

forme pharmaceutique:

TABLET

Composition:

DOXYCYCLINE (DOXYCYCLINE HYCLATE) 100MG

Mode d'administration:

ORAL

Unités en paquet:

10/20/100/300

Type d'ordonnance:

Prescription

Domaine thérapeutique:

TETRACYCLINES

Descriptif du produit:

Active ingredient group (AIG) number: 0105569001; AHFS:

Statut de autorisation:

MARKETED

Date de l'autorisation:

1989-12-31

Résumé des caractéristiques du produit

_Prescribing Information – DOXYCIN CAPSULES AND DOXYCIN TABLETS_
_ _
_Page 1 of 25_
_ _
_ _
_ _
_ _
_ _
_ _
_ _
PRESCRIBING INFORMATION AND PATIENT MEDICATION INFORMATION
PR
DOXYCIN CAPSULES
100MG
Doxycycline Hyclate Capsules, USP
_100 mg doxycycline (as hyclate)_
PR
DOXYCIN TABLETS
100MG
Doxycycline Hyclate Tablets, USP
_100 mg doxycycline (as hyclate)_
Antibiotic
LABORATOIRE RIVA INC.
660 Industriel Blvd.
Blainville, Canada
J7C 3V4
www.labriva.com
Date of Revision:
April 5, 2018
Control #: 211564
_Prescribing Information – DOXYCIN CAPSULES AND DOXYCIN TABLETS_
_ _
_Page 2 of 25_
_ _
NAME OF DRUGS
PR
DOXYCIN CAPSULES
Doxycycline Hyclate Capsules, USP
_100mg doxycycline (as hyclate) _
PR
DOXYCIN TABLETS
Doxycycline Hyclate Tablets, USP
_100mg doxycycline (as hyclate)_
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION
Doxycycline hyclate is a broad-spectrum antibiotic and is active
against a wide range of Gram-
negative and Gram-positive organisms. Doxycycline exerts its
bacteriostatic effect by the inhibition of
protein synthesis.
INDICATIONS AND CLINICAL USE
DOXYCIN CAPSULES AND DOXYCIN TABLETS
(doxycycline hyclate) may be indicated for
the treatment of:
Pneumonia:
Single and multilobe pneumonia and bronchopneumonia due to susceptible
strains of
_Streptococcus _
_pneunomiae_
and other
_Streptococcus_
spp.,
_Staphylococcus_
spp.,
_H. influenzae_
and
_Klebsiella _
_pneumoniae_
.
Other Respiratory Tract Infections:
Pharyngitis, tonsillitis, sinusitis, otitis media, bronchitis caused
by susceptible strains of β-hemolytic
_Streptococcus_
,
_Staphylococcus _
spp.,
_Streptococcus pneunomiae_
and
_H._
_influenzae_
.
Genitourinary Tract Infections:
Pyelonephritis, cystitis, urethritis caused by susceptible strains of
_Klebsiella_
spp.,
_Enterobacter _
_aerogenes, E. coli_
,
_Enterococcus_
spp.,
_Staphylococcus_
spp.,
_Streptococcus_
spp. and gonococcal
urethritis caused by
_Neisseria gonorrhoeae. _
In adult patients with urethritis, cervicitis and vaginitis with a
positive test for
_Chlamydia trachomatis_
and/or
_Ureapla